ArticleDisease markers2020

Association of the Sialylation of Antibodies Specific to the HCV E2 Envelope Glycoprotein with Hepatic Fibrosis Progression and Antiviral Therapy Efficacy.

Oleg Kurtenkov et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.